(Reuters) – Johnson & Johnson MedTech unit said on Tuesday it would submit an application to the U.S. Food & Drug Administration in the second half of 2024 to initiate clinical trials of its robotic surgical system.
(Reporting by Sriparna Roy in Bengaluru; Editing by Anil D’Silva)
